E76.210 ICD-10-CM Code: Morquio A mucopolysaccharidoses
E76.210 maps to CMS-HCC V28 49. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Metabolic disorders (E70-E88)
E76.210
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMorquio A mucopolysaccharidoses
Morquio A mucopolysaccharidosis is a rare inherited metabolic disorder characterized by severe skeletal deformities, short stature, and progressive joint and spine problems due to accumulation of complex sugars.

Buddy Insight
Morquio A mucopolysaccharidosis (MPS IVA) is caused by deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), leading to accumulation of keratan sulfate and chondroitin-6-sulfate.
CMS-HCC V28
MappedHCC 49
Coefficient HCC 49: 9.256 (Community Non-Dual Aged (CNA))
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 026
Code-level coefficient reference
ESRD/PACE
MappedHCC 23
Code-level coefficient reference
RXHCC
MappedHCC 41
Code-level coefficient reference
Code Book Path
Inclusion Terms
Official- Classic Morquio syndrome
- Morquio syndrome A
- Mucopolysaccharidosis, type IVA
Excludes 2
Official- Ehlers-Danlos syndromes (Q79.6-)Inherited from E70-E88
Related Codes
Includes
OfficialNo Includes notes are included in this display for E76.210. Check the code and parent instructions in the Code Book.
Excludes 1
Official- transitory endocrine and metabolic disorders specific to newborn (P70-P74)Inherited from E00-E89, E70-E88
- androgen insensitivity syndrome (E34.5-)Inherited from E00-E89, E70-E88
- congenital adrenal hyperplasia (E25.0)Inherited from E00-E89, E70-E88
- hemolytic anemias attributable to enzyme disorders (D55.-)Inherited from E00-E89, E70-E88
- Marfan syndrome (Q87.4-)Inherited from E00-E89, E70-E88
- 5-alpha-reductase deficiency (E29.1)Inherited from E00-E89, E70-E88
Code First
OfficialNo Code First sequencing instructions are included in this display for E76.210. Check the code and parent instructions in the Code Book.
Use Additional
OfficialNo Use Additional Code instructions are included in this display for E76.210. Check the code and parent instructions in the Code Book.
Code Also
OfficialNo Code Also instructions are included in this display for E76.210. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is E76.210 an HCC code?
Yes. E76.210 (Morquio A mucopolysaccharidoses) maps to HCC 49, Specified Lysosomal Storage Disorders under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 9.256. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.
Coder answer: E76.210 is billable and maps to V28 HCC 49, Specified Lysosomal Storage Disorders. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- E76.210
- Description
- Morquio A mucopolysaccharidoses
- HCC (V28)
- HCC 49 — Specified Lysosomal Storage Disorders
- RAF reference coefficient
- 9.256
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work E76.210 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for E76.210
For E76.210, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E76.210 is the ICD-10-CM diagnosis code for morquio a mucopolysaccharidoses. Morquio A mucopolysaccharidosis is a rare inherited metabolic disorder characterized by severe skeletal deformities, short stature, and progressive joint and spine problems due to accumulation of complex sugars. E76.210 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering metabolic disorders (e70-e88).
Under the CMS-HCC V28 risk adjustment model, E76.210 maps to Specified Lysosomal Storage Disorders (HCC 49) with a source-labeled community, non-dual, aged reference coefficient of 9.256. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.
Morquio A is the classic form; ensure you are not confusing it with Morquio B, which has different enzyme deficiency. For E76.210, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for E76.210 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Morquio A is the classic form; ensure you are not confusing it with Morquio B, which has different enzyme deficiency
- •Document associated complications such as cardiac valve disease, hearing loss, or vision problems for comprehensive coding
Clinical Significance
Morquio A mucopolysaccharidosis (MPS IVA) is caused by deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), leading to accumulation of keratan sulfate and chondroitin-6-sulfate. It primarily affects the skeleton with severe short stature, spinal cord compression risk, and joint laxity while preserving intelligence, making it distinct from many other MPS types.
Documentation Requirements
- ✓Specific diagnosis of Morquio A syndrome (MPS IVA) documented
- ✓Confirmatory enzyme assay showing GALNS deficiency or genetic testing with GALNS gene mutation
- ✓Skeletal manifestations: short trunk dwarfism, pectus carinatum, genu valgum, odontoid hypoplasia
- ✓Cervical spine stability assessment (risk of atlantoaxial subluxation/spinal cord compression)
- ✓Treatment plan including enzyme replacement therapy (elosulfase alfa/Vimizim), surgical interventions, or supportive care
Commonly Confused Codes
- •E76.211: Morquio B (MPS IVB): different enzyme deficiency (beta-galactosidase), same skeletal phenotype
- •E76.219: Morquio, unspecified: use only when A vs. B subtype is not documented
- •E76.1: Hunter syndrome (MPS II): has skeletal features but also hepatosplenomegaly and potential neurodegeneration
- •Q77.4: Achondroplasia: skeletal dysplasia that may mimic Morquio radiographically but is a different entity
- •E76.22: Sanfilippo syndrome (MPS III): primarily neurological, not skeletal

